Molecular markers of VEGF, TNF-α and TNF-β IN bladder cancer patients at stage T3N0M0 and their relationship with the degree of tumor neoplasia
DOI:
https://doi.org/10.12775/JEHS.2023.13.04.044Keywords
carcinoma, urinary bladder, genotype, growth factor, necrosis factor, polymorphism, differentiationAbstract
17 bladder cancer patients, stage T3N0M0 (main group), were included in the study. There were 10 men (mean age 58.2 ± 6.2 years) and 7 women (mean age 59.5 ± 2.4 years). Clinical data of 12 healthy individuals were used as a control. According to statistic data, the average level of VEGF in bladder cancer patients urine was 246.55± 6.90 pg/ml which significantly exceeded this indicator in the control group (129.21± 7.60 pg/ml), the difference was statistically significant At bladder cancer diagnosis the sensitivity and specificity of the urinary level of TNF-α was low and amounted to 30% and 20%, respectively, and the level of TNF-β was even lower - 25% and 20%, respectively, which is not representative for the pathology under study.
References
Chen CH, Ho CH, Kuan-Hua Huang S, Shen CH, Wu CC, Wang YH. Association between VEGF gene promoter polymorphisms and bladder cancer: An updated meta-analysis. Cytokine. 2020 Jul;131:155112. doi: 10.1016/j.cyto.2020.155112
Ting HK, Chen CL, Meng E, Cherng JH, Chang SJ, Kao CC, Yang MH, Leung FS, Wu ST. Inflammatory Regulation by TNF-α-Activated Adipose-Derived Stem Cells in the Human Bladder Cancer Microenvironment. Int J Mol Sci. 2021 Apr 13;22(8):3987. doi: 10.3390/ijms22083987
El Azzouzi M, El Ahanidi H, Hafidi Alaoui C, Chaoui I, Benbacer L, Tetou M, Hassan I, Bensaid M, Oukabli M, Ameur A, Al Bouzidi A, Attaleb M, El Mzibri M. The Evaluation of Vascular Endothelial Growth Factor A (VEGFA) and VEGFR2 Receptor as Prognostic Biomarkers in Bladder Cancer. Diagnostics (Basel). 2023 Apr 19;13(8):1471. doi: 10.3390/diagnostics13081471
Kim Y.-J., Chung W.C., Jun K.-H., Chin H.-M. Genetic Polymorphisms of Vascular Endothelial Growth Factor (VEGF) Associated with Gastric Cancer Recurrence after Curative Resection with Adjuvant Chemotherapy. BMC Cancer. 2019;19:483. doi: 10.1186/s12885-019-5702-5.
Song Y, Hu J, Chen Q, Guo J, Zou Y, Zhang W, Chen X, Hu W, Huang P. Association between vascular endothelial growth factor rs699947 polymorphism and the risk of three major urologic neoplasms (bladder cancer, prostate cancer, and renal cell carcinoma): A meta-analysis involving 11,204 subjects. Gene. 2018 Dec 30;679:241-252. doi: 10.1016/j.gene.2018.09.005
Chen J.-B., Zhang M., Cui Y., Liu P.-H., Qi Y.-W., Li C., Cheng X., Ren W.-B., Li Q.-Q., Liu L.-F., et al. Association Between 12 Polymorphisms of VEGF/Hypoxia/Angiogenesis Pathway Genes and Risk of Urogenital Carcinomas: A Meta-Analysis Based on Case-Control Studies. Front. Physiol. 2018;9:715. doi: 10.3389/fphys.2018.00715
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 O. Fedevych, V. Fedevych, S. Pasichnyk
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 262
Number of citations: 0
